Skip to main content
OpenTrials
Completed

NCT Number: NCT04505280

Greater Occipital Nerve and Cervical Region Injection in Patients With Trigeminal Neuralgia

The aim of this study is to investigate the efficacy of greater occipital nerve block and cervical injections with lidocaine

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Afyonkarahisar University of Health Sciences

Afyonkarahisar, Kartal/Soğanlık, 03217, Turkey (Türkiye)

About this study

After being informed about the study and potantiel risks, all patients giving informed consent will undergo randomization in 1:1 ratio to 1% lidocaine or 0.9% saline groups

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Classical Trigeminal Neuralgia

Exclusion criteria

  • Secondary Trigeminal Neuralgia

Treatment and study plan

Lidocaine 1% Injectable Solution

Drug

Greater occipital nerve and cervical region injections once a week for 4 weeks

Primary outcomes

  1. Efficacy on pain severity

    Time frame: 3 months

    Efficacy on pain scores. Visual Analogue Scale (VAS). VAS is a ten-point scale where zero refers to no pain and ten refers to maximal pain

  2. Efficacy on pain frequency

    Time frame: 3 months

    Pain frequency per day

Sponsors and collaborators

Lead sponsor

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Other Gov

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Aug 10, 2020
Registry last updated
Feb 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.